ERS 2025: Long-term CFTR use shows clinical benefit but variable microbial impact
At the 2025 European Respiratory Society (ERS) International Congress taking place in Amsterdam, the Netherlands, from 27 September to 1…
Immunology
-
-
ERS 2025: APG808 to address need for biologic for moderate asthma
At the 2025 European Respiratory Society (ERS) International Congress takig place in Amsterdam, the Netherlands, from 27 September to 1…
-
Roche bids to broaden MS pipeline and strengthen Ocrevus influence
Roche plans to present data at a major multiple sclerosis (MS) conference indicating the continued efficacy of its investigational Bruton…
-
FUJIFILM Biotechnologies and argenx expand global partnership
FUJIFILM Biotechnologies has expanded its global partnership with immunology company argenx to manufacture the latter’s drug substance for efgartigimod at…
-
aTyr Pharma stock crashes on Phase III pulmonary sarcoidosis fail
aTyr Pharma shares plunged more than 80% after its Phase III trial in pulmonary sarcoidosis failed to meet its primary…
-
Novartis returns to Monte Rosa for second time in a year with $5.7bn deal
Novartis has ventured back to Monte Rosa Therapeutics tasked with finding more immune-mediated disease drug candidates, signing a licensing deal…
-
AbbVie extends Rinvoq exclusivity by four years after generics settlements
AbbVie has bolstered the sales outlook of its blockbuster autoimmune drug Rinvoq (upadacitinib) by extending its exclusivity until 2037. The…
-
Oxford University and Ellison Institute link for AI vaccine research
The University of Oxford has announced the launch of a new vaccine research programme in collaboration with the Ellison Institute…
-
Moderna’s updated Covid-19 vaccine gets Canadian approval
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 LP.8.1 variant.…
-
Sanofi receives orphan status from EMA for rilzabrutinib
Sanofi has received orphan designation from the European Medicines Agency (EMA) for rilzabrutinib, a reversible covalent Bruton’s tyrosine kinase (BTK)…
